Bridgeway Capital Management, LLC Insulet Corp Transaction History

Bridgeway Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$272.48 - $330.23 $3.76 Million - $4.56 Million	13,800 Added 226.23%	19,900 $5.74 Million
Q1 2023 May 15, 2023	BUY	$276.36 - $326.03 $1.69 Million - $1.99 Million	6,100 New	6,100 $1.95 Million
Q4 2020 Feb 16, 2021	SELL	$215.97 - $265.89 $1.75 Million - $2.15 Million	-8,100 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$192.55 - $236.59 $1.88 Million - $2.31 Million	-9,780 Reduced 54.7%	8,100 $1.92 Million
Q2 2020 Aug 14, 2020	SELL	$159.17 - $224.73 $1.62 Million - $2.29 Million	-10,170 Reduced 36.26%	17,880 $3.47 Million
Q4 2019 Feb 14, 2020	BUY	$144.81 - $186.0 $195,493 - $251,100	1,350 Added 5.06%	28,050 $4.8 Million
Q3 2019 Nov 14, 2019	BUY	$117.35 - $167.95 $3.13 Million - $4.48 Million	26,700 New	26,700 $4.4 Million

723

63.3M

640K

858K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.6B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.